Kuder Kamil J, Łażewska Dorota, Kaleta Maria, Latacz Gniewomir, Kottke Tim, Olejarz Agnieszka, Karcz Tadeusz, Fruziński Andrzej, Szczepańska Katarzyna, Karolak-Wojciechowska Janina, Stark Holger, Kieć-Kononowicz Katarzyna
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, Kraków 30-688, Poland.
Institute of Pharmaceutical Chemistry, Biozentrun, ZAFES, Frankfurt/Main 60438, Germany.
Bioorg Med Chem. 2017 May 15;25(10):2701-2712. doi: 10.1016/j.bmc.2017.03.031. Epub 2017 Mar 21.
As a continuation of our search for novel histamine H receptor ligands a series of twenty new tert-amyl phenoxyalkylamine derivatives (2-21) was synthesized. Compounds of four to eight carbon atoms spacer alkyl chain were evaluated on their binding properties at human histamine H receptor (hHR). The highest affinities were observed for pentyl derivatives 6-8 (K=8.8-23.4nM range) and among them piperidine derivative 6 with K=8.8nM. Structures 6, 7 were also classified as antagonists in cAMP accumulation assay (with EC=157 and 164nM, respectively). Moreover, new compounds were also evaluated for anticonvulsant activity in Antiepileptic Screening Program (ASP) at National Institute of Neurological Disorders and Stroke (USA). Seven compounds (2-4, 9, 11, 12 and 20) showed anticonvulsant activity at maximal electroshock (MES) test in the dose of 30mg/kg at 0.5h. In the subcutaneous pentetrazole (scMET) test compound 4 showed protection at 100 and 300mg/kg dose at mice, however compounds showed high neurotoxicity in rotarod test at used doses. Also, molecular modeling studies were undertaken, to explain affinity of compounds at hHR (taking into the consideration X-ray analysis of compound 18). In order to estimate "drug-likeness" of selected compounds in silico and experimental evaluation of lipophilicity, metabolic stability and cytotoxicity was performed.
作为我们寻找新型组胺H受体配体工作的延续,合成了一系列20种新的叔戊基苯氧基烷基胺衍生物(2 - 21)。对具有4至8个碳原子间隔烷基链的化合物进行了人组胺H受体(hHR)结合特性评估。戊基衍生物6 - 8表现出最高亲和力(K值在8.8 - 23.4 nM范围内),其中哌啶衍生物6的K值为8.8 nM。在cAMP积累试验中,化合物6、7也被归类为拮抗剂(EC分别为157和164 nM)。此外,在美国国立神经疾病和中风研究所的抗癫痫筛选项目(ASP)中,还对新化合物的抗惊厥活性进行了评估。7种化合物(2 - 4、9、11、12和20)在30mg/kg剂量、0.5小时时的最大电休克(MES)试验中表现出抗惊厥活性。在皮下注射戊四氮(scMET)试验中,化合物4在100和300mg/kg剂量下对小鼠有保护作用,但在所使用剂量下,这些化合物在转棒试验中表现出高神经毒性。同时,还进行了分子模拟研究,以解释化合物对hHR的亲和力(考虑到化合物18的X射线分析)。为了在计算机模拟中评估所选化合物的“类药性质”,并对亲脂性、代谢稳定性和细胞毒性进行了实验评估。